Industry Insights


Welcome to our Industry Insights section—your gateway to knowledge, context, and clarity across the aerospace and aviation landscape. From market trends and regulatory shifts to cutting-edge innovations and sector-specific analysis, this section is curated for professionals who need to stay ahead of the curve. Whether you operate in commercial aviation, regional markets, defense, or the expanding space economy, we deliver timely and relevant insights designed to help you make informed decisions and respond strategically.

Explore each of our focused sub-sections to access targeted analysis by sector


  • Commercial Aviation
  • Regional Aircraft
  • Business Aviation
  • Helicopters
  • OEM Components
  • Aerospace
  • Space
  • Defense & Military
  • Aircraft MRO
  • Engines
  • Business Transformation

Thank you for choosing Blu Dot Aero as your source for industry intelligence. Stay connected. Stay informed.


Artificial Intelligence in Neuro-Ophthalmology for Optic Disc Pathologies and Neurodegenerative Disease Business Transformation
Mar 14, 2026
Artificial Intelligence in Neuro-Ophthalmology for Optic Disc Pathologies and Neurodegenerative Disease

… that autonomous or assistive artificial intelligence (AI) systems can...

Read More
Artificial Intelligence in Neuro-Ophthalmology for Optic Disc Pathologies and Neurodegenerative Disease Business Transformation
Mar 14, 2026
Artificial Intelligence in Neuro-Ophthalmology for Optic Disc Pathologies and Neurodegenerative Disease

… that autonomous or assistive artificial intelligence (AI) systems can...

Read More
Artificial Intelligence in Neuro-Ophthalmology for Optic Disc Pathologies and Neurodegenerative Disease Business Transformation
Mar 14, 2026
Artificial Intelligence in Neuro-Ophthalmology for Optic Disc Pathologies and Neurodegenerative Disease

… that autonomous or assistive artificial intelligence (AI) systems can...

Read More
Artificial Intelligence in Neuro-Ophthalmology for Optic Disc Pathologies and Neurodegenerative Disease Business Transformation
Mar 14, 2026
Artificial Intelligence in Neuro-Ophthalmology for Optic Disc Pathologies and Neurodegenerative Disease

… that autonomous or assistive artificial intelligence (AI) systems can...

Read More
Artificial Intelligence in Neuro-Ophthalmology for Optic Disc Pathologies and Neurodegenerative Disease Business Transformation
Mar 14, 2026
Artificial Intelligence in Neuro-Ophthalmology for Optic Disc Pathologies and Neurodegenerative Disease

… that autonomous or assistive artificial intelligence (AI) systems can...

Read More
Artificial Intelligence as a Disruptive Force in Pharmaceutical Innovation: Transforming Discovery, Development, and Manufacturing Business Transformation
Mar 14, 2026
Artificial Intelligence as a Disruptive Force in Pharmaceutical Innovation: Transforming Discovery, Development, and Manufacturing

… 47;en/use-artificial-intelligence-ai-medicinal-product-lifecycle-scientific-guideline. Accessed … atories with artificial intelligence: an overview...

Read More
Artificial Intelligence as a Disruptive Force in Pharmaceutical Innovation: Transforming Discovery, Development, and Manufacturing Business Transformation
Mar 14, 2026
Artificial Intelligence as a Disruptive Force in Pharmaceutical Innovation: Transforming Discovery, Development, and Manufacturing

… 47;en/use-artificial-intelligence-ai-medicinal-product-lifecycle-scientific-guideline. Accessed … atories with artificial intelligence: an overview...

Read More
Artificial Intelligence as a Disruptive Force in Pharmaceutical Innovation: Transforming Discovery, Development, and Manufacturing Business Transformation
Mar 14, 2026
Artificial Intelligence as a Disruptive Force in Pharmaceutical Innovation: Transforming Discovery, Development, and Manufacturing

… 47;en/use-artificial-intelligence-ai-medicinal-product-lifecycle-scientific-guideline. Accessed … atories with artificial intelligence: an overview...

Read More
Artificial Intelligence as a Disruptive Force in Pharmaceutical Innovation: Transforming Discovery, Development, and Manufacturing Business Transformation
Mar 14, 2026
Artificial Intelligence as a Disruptive Force in Pharmaceutical Innovation: Transforming Discovery, Development, and Manufacturing

… 47;en/use-artificial-intelligence-ai-medicinal-product-lifecycle-scientific-guideline. Accessed … atories with artificial intelligence: an overview...

Read More
Artificial Intelligence as a Disruptive Force in Pharmaceutical Innovation: Transforming Discovery, Development, and Manufacturing Business Transformation
Mar 14, 2026
Artificial Intelligence as a Disruptive Force in Pharmaceutical Innovation: Transforming Discovery, Development, and Manufacturing

… 47;en/use-artificial-intelligence-ai-medicinal-product-lifecycle-scientific-guideline. Accessed … atories with artificial intelligence: an overview...

Read More
Artificial Intelligence as a Disruptive Force in Pharmaceutical Innovation: Transforming Discovery, Development, and Manufacturing Business Transformation
Mar 14, 2026
Artificial Intelligence as a Disruptive Force in Pharmaceutical Innovation: Transforming Discovery, Development, and Manufacturing

… 47;en/use-artificial-intelligence-ai-medicinal-product-lifecycle-scientific-guideline. Accessed … atories with artificial intelligence: an overview...

Read More
Artificial Intelligence as a Disruptive Force in Pharmaceutical Innovation: Transforming Discovery, Development, and Manufacturing Business Transformation
Mar 14, 2026
Artificial Intelligence as a Disruptive Force in Pharmaceutical Innovation: Transforming Discovery, Development, and Manufacturing

… 47;en/use-artificial-intelligence-ai-medicinal-product-lifecycle-scientific-guideline. Accessed … atories with artificial intelligence: an overview...

Read More
Artificial Intelligence as a Disruptive Force in Pharmaceutical Innovation: Transforming Discovery, Development, and Manufacturing Business Transformation
Mar 14, 2026
Artificial Intelligence as a Disruptive Force in Pharmaceutical Innovation: Transforming Discovery, Development, and Manufacturing

… 47;en/use-artificial-intelligence-ai-medicinal-product-lifecycle-scientific-guideline. Accessed … atories with artificial intelligence: an overview...

Read More
Artificial Intelligence as a Disruptive Force in Pharmaceutical Innovation: Transforming Discovery, Development, and Manufacturing Business Transformation
Mar 14, 2026
Artificial Intelligence as a Disruptive Force in Pharmaceutical Innovation: Transforming Discovery, Development, and Manufacturing

… 47;en/use-artificial-intelligence-ai-medicinal-product-lifecycle-scientific-guideline. Accessed … atories with artificial intelligence: an overview...

Read More
Artificial Intelligence as a Disruptive Force in Pharmaceutical Innovation: Transforming Discovery, Development, and Manufacturing Business Transformation
Mar 14, 2026
Artificial Intelligence as a Disruptive Force in Pharmaceutical Innovation: Transforming Discovery, Development, and Manufacturing

… 47;en/use-artificial-intelligence-ai-medicinal-product-lifecycle-scientific-guideline. Accessed … atories with artificial intelligence: an overview...

Read More
eXoZymes’ CCO Damien Perriman to Present an NCT Solution at Next Week’s MISTA Symposium Commercial
Mar 14, 2026
eXoZymes’ CCO Damien Perriman to Present an NCT Solution at Next Week’s MISTA Symposium

eXoZymes Inc. (NASDAQ:EXOZ) LOS ANGELES, CA, UNITED STATES, March 13,...

Read More
eXoZymes’ CCO Damien Perriman to Present an NCT Solution at Next Week’s MISTA Symposium Commercial
Mar 14, 2026
eXoZymes’ CCO Damien Perriman to Present an NCT Solution at Next Week’s MISTA Symposium

eXoZymes Inc. (NASDAQ:EXOZ) LOS ANGELES, CA, UNITED STATES, March 13,...

Read More
eXoZymes’ CCO Damien Perriman to Present an NCT Solution at Next Week’s MISTA Symposium Commercial
Mar 14, 2026
eXoZymes’ CCO Damien Perriman to Present an NCT Solution at Next Week’s MISTA Symposium

eXoZymes Inc. (NASDAQ:EXOZ) LOS ANGELES, CA, UNITED STATES, March 13,...

Read More
eXoZymes’ CCO Damien Perriman to Present an NCT Solution at Next Week’s MISTA Symposium Commercial
Mar 14, 2026
eXoZymes’ CCO Damien Perriman to Present an NCT Solution at Next Week’s MISTA Symposium

eXoZymes Inc. (NASDAQ:EXOZ) LOS ANGELES, CA, UNITED STATES, March 13,...

Read More
eXoZymes’ CCO Damien Perriman to Present an NCT Solution at Next Week’s MISTA Symposium Commercial
Mar 14, 2026
eXoZymes’ CCO Damien Perriman to Present an NCT Solution at Next Week’s MISTA Symposium

eXoZymes Inc. (NASDAQ:EXOZ) LOS ANGELES, CA, UNITED STATES, March 13,...

Read More